Approvals/HSA/CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL

Approved

THERAPEUTIC

CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL

Approval Date: Apr 12, 2016
Approval ID: 7b4b62a638dfe1c9
Company: LABESFAL LABORATORIOS ALMIRO S.A. (FRESENIUS KABI GROUP) (PRIMARY AND SECONDARY PACKING) - PORTUGALFRESENIUS KABI IPSUM S.R.L (ITALY)
Type: Therapeutic

Approval Id: 7b4b62a638dfe1c9
Drug Name: CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL
Product Name: CEFEPIME KABI POWDER FOR SOLUTION FOR INJECTION OR INFUSION 2 G/VIAL
Approval Number: SIN14988P
Approval Date: 2016-04-12
Registrant: FRESENIUS KABI (SINGAPORE) PTE LTD
Licence Holder: FRESENIUS KABI (SINGAPORE) PTE LTD
Drug Type: Therapeutic
Forensic Classification: PRESCRIPTION ONLY MEDICINES
Dosage Form: INJECTION, POWDER, FOR SOLUTION
Route Of Administration: INTRAVENOUS
Atc Code: J01DE01
Atc Item Name: cefepime
Pharma Manufacturer Name: FRESENIUS KABI (SINGAPORE) PTE LTD
Company Detail Path: /organization/fresenius-kabi-singapore-pte-ltd

Cefepime dihydrochloride monohydrate 2378.5mg eqv cefepime

2000 mg/vial

CEFEPIME DIHYDROCHLORIDE MONOHYDRATE 2,378.5 MG EQV CEFEPIME

2,000 MG/VIAL

Approved

Agency

HSA

Country

🇸🇬

Approval Date

Apr 12, 2016

Approval ID

7b4b62a638dfe1c9

Type

Therapeutic